IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors
Shwu‐Yuan Wu(The University of Texas Southwestern Medical Center), Cheng‐Ming Chiang(The University of Texas Southwestern Medical Center)
Cited by 28
Related Papers
Faculty Opinions recommendation of The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2019|0
Faculty Opinions recommendation of TIP60 represses activation of endogenous retroviral elements.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2018|0
Faculty Opinions recommendation of ZFAT binds to centromeres to control noncoding RNA transcription through the KAT2B-H4K8ac-BRD4 axis.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2020|0